List was last updated on
.-
- We All Love a Good Book or Movie.
- [No author given]
- FORCE. Blog. 2023 Jan 23.
- Blog post
- Free Full Text
-
- Impact of the coverage of risk-reducing salpingo-oophorectomy by the national insurance system for women with BRCA pathogenic variants in Japan.
- Nomura H, Abe A, Fusegi A, Yoshimitsu T, Misaka S, Murakami A, Matsumoto T, Tsumura S, Kanno M, Aoki Y, Netsu S, Omi M, Tanigawa T, Okamoto S, Omatsu K, Yunokawa M, Kanao H, Habano E, Arakawa H, Kaneko K, Ueki A, Haruyama Y, Inari H, Ueno T.
- Sci Rep. 2023 Jan 19;13(1):1018. doi: 10.1038/s41598-023-28304-w.
- PMID: 36658289
- PubMed abstract
-
- Factors that influence the management recommendations breast surgeons provide to women with pathogenic variants in moderate penetrance breast cancer susceptibility genes.
- Vanderwal A, Lewis J, Basil J, Atzinger C, Widmeyer K.
- J Genet Couns. 2023 Jan 15. doi: 10.1002/jgc4.1674. Epub ahead of print.
- PMID: 36642783
- PubMed abstract
- Source abstract
-
- Effectiveness of Secondary Risk-Reducing Strategies in Patients With Unilateral Breast Cancer With Pathogenic Variants of BRCA1 and BRCA2 Subjected to Breast-Conserving Surgery: Evidence-Based Simulation Study.
- Maksimenko J, Rodrigues PP, Nakazawa-Miklaševiča M, Pinto D, Miklaševičs E, Trofimovičs G, Gardovskis J, Cardoso F, Cardoso MJ.
- JMIR Form Res. 2022 Dec 29;6(12):e37144. doi: 10.2196/37144.
- PMID: 36580360
- PubMed abstract
-
- The risks of cancer in older women with BRCA pathogenic variants: How far have we come?
- Metcalfe KA, Gronwald J, Tung NM, McCuaig JM, Eisen A, Elser C, Foulkes WD, Neuhausen SL, Senter L, Moller P, Bordeleau L, Fruscio R, Velsher L, Zakalik D, Olopade OI, Eng C, Pal T, Cullinane CA, Couch FJ, Kotsopoulos J, Sun P, Lubinski J, Narod SA.
- Cancer. 2022 Dec 26. doi: 10.1002/cncr.34615. Epub ahead of print.
- PMID: 36571512
- PubMed abstract
- Source abstract
-
- All HER2-negative breast cancer patients need gBRCA testing: cost-effectiveness and clinical benefits.
- Wu HL, Luo ZY, He ZL, Gong Y, Mo M, Ming WK, Liu GY.
- Br J Cancer. 2022 Dec 23. doi: 10.1038/s41416-022-02111-y. Epub ahead of print.
- PMID: 36564566
- PubMed abstract
-
- Risk-Reducing Salpingo-Oophorectomy (RRSO) Combined with Simultaneous Mastectomy in Women with BRCA 1-2 Mutation Carriers: The Surgical Technique, the Feasibility and Patients' Satisfaction of Multiple Surgeries.
- Saccardi C, Spagnol G, Saibene T, De Lorenzo LS, Marchetti M, Bonaldo G, Michieletto S, Toffanin MC, Noventa M, Tozzi R.
- J Clin Med. 2022 Dec 18;11(24):7502. doi: 10.3390/jcm11247502.
- PMID: 36556118
- PubMed abstract
-
- Cost-Effectiveness of Risk-Reducing Surgery for Breast and Ovarian Cancer Prevention: A Systematic Review.
- Wei X, Oxley S, Sideris M, Kalra A, Sun L, Yang L, Legood R, Manchanda R.
- Cancers (Basel). 2022 Dec 12;14(24):6117. doi: 10.3390/cancers14246117.
- Review
- Free Full Text
-
- Controversies and Open Questions in Management of Cancer-Free Carriers of Germline Pathogenic Variants in BRCA1/BRCA2.
- Bernstein-Molho R, Friedman E, Evron E.
- Cancers (Basel). 2022 Sep 22;14(19):4592. doi: 10.3390/cancers14194592.
- PMID: 36230512
- PubMed abstract
- Source abstract
- Review
- Free PMC article
- Free Full Text
s
-
- Breast cancer risk reduction: who, why, and what?
- Bozzuto LM.
- Best Pract Res Clin Obstet Gynaecol. 2022 Sep;83:36-45. doi: 10.1016/j.bpobgyn.2021.11.012. Epub 2021 Dec 8.
- PMID: 34991977
- PubMed abstract
- Source abstract
-
- Optimal breast cancer risk reduction policies tailored to personal risk level.
- Ergun MA, Hajjar A, Alagoz O, Rampurwala M.
- Health Care Manag Sci. 2022 Sep;25(3):363-388. doi: 10.1007/s10729-022-09596-2. Epub 2022 Jun 10.
- PMID: 35687269
- PubMed abstract
- Source abstract
-
- Breast cancer in a teenage girl with BRCA mutation: A case report from a low middle-income country.
- Vohra LM, Ali D, Hashmi SA, Angez M.
- Int J Surg Case Rep. 2022 Sep;98:107513. doi: 10.1016/j.ijscr.2022.107513. Epub 2022 Aug 13.
- PMID: 36027825
- PubMed abstract
- Case report
- Free PMC article
- Free Full Text
-
- A prospective multicentric study of risk-reducing salpingo-oophorectomy in BRCA mutation patients.
- Loizzi V, Cicinelli E, Del Vecchio V, Arezzo F, Deromemaj X, Kardhashi A, Paradiso A, Legge F, Natalicchio MI, Resta L, Resta N, Loconte DC, Cormio G.
- Acta Biomed. 2022 Aug 31;93(4):e2022051. doi: 10.23750/abm.v93i4.11695.
- PMID: 36043985
- PubMed abstract
- Source abstract
-
- Risk-reducing surgery in unaffected individuals receiving cancer genetic testing in an integrated health care system.
- Knerr S, Guo B, Mittendorf KF, Feigelson HS, Gilmore MJ, Jarvik GP, Kauffman TL, Keast E, Lynch FL, Muessig KR, Okuyama S, Veenstra DL, Zepp JM, Goddard KAB, Devine B.
- Cancer. 2022 Aug 15;128(16):3090-3098. doi: 10.1002/cncr.34349. Epub 2022 Jun 9.
- PMID: 35679147
- PubMed abstract
- Source abstract
-
- Cost-utility analysis of risk-reducing strategies to prevent breast and ovarian cancer in BRCA-mutation carriers in Switzerland.
- Bommer C, Lupatsch J, Bürki N, Schwenkglenks M.
- Eur J Health Econ. 2022 Jul;23(5):807-821. doi: 10.1007/s10198-021-01396-9. Epub 2021 Nov 12.
- PMID: 34767113
- PubMed abstract
-
- Cancer risk-reducing surgery: Brazilian society of surgical oncology guideline part 1 (gynecology and breast).
- Carneiro VCG, Gifoni ACLVC, Mauro Rossi B, Andrade CEMDC, Lima FT, Galvão HCR, Casali da Rocha JC, Silva Barreto LSD, Ashton-Prolla P, Guindalini RSC, Farias TP, Andrade WP, Fernandes PHS, Ribeiro R, Lopes A, Tsunoda AT, Azevedo BRB, Marins CAM, Oliveira Uchôa DNA, Dos Santos EAS, Fernández Coimbra FJ, Dias Filho FA, Lopes FCO, Fernandes FG, Ritt GF, Laporte GA, Guimaraes GC, Feitosa E Castro Neto H, Dos Santos JC, de Carvalho Vilela JB, Meinhardt Junior JG, Cunha JRD, Medeiros Milhomem L, da Silva LM, Maciel LF, Ramalho NM, Leite Nunes R, Guido de Araújo R, de Assunção Ehrhardt R, Delgado Bocanegra RE, Silva Junior TC, Oliveira VR, Silva Surimã W, de Melo Melquiades M, Ribeiro HSC, Oliveira AF.
- J Surg Oncol. 2022 Jul;126(1):10-19. doi: 10.1002/jso.26812.
- PMID: 35689574
- PubMed abstract
- Source abstract
-
- Combining Breast and Ovarian Operations Increases Complications.
- Henn D, Barrera JA, Sivaraj D, Lin JQ, Rizk NM, Ma I, Gurtner GC, Lee GK, Nazerali RS.
- Plast Reconstr Surg. 2022 May 1;149(5):1050-1059. doi: 10.1097/PRS.0000000000008984. Epub 2022 Mar 2.
- PMID: 35245249
- PubMed abstract
- Source abstract
-
- Oral Contraceptive Use in BRCA1 and BRCA2 Mutation Carriers: Absolute Cancer Risks and Benefits.
- Schrijver LH, Mooij TM, Pijpe A, Sonke GS, Mourits MJE, Andrieu N, Antoniou AC, Easton DF, Engel C, Goldgar D, John EM, Kast K, Milne RL, Olsson H, Phillips KA, Terry MB, Hopper JL, van Leeuwen FE, Rookus MA.
- J Natl Cancer Inst. 2022 Apr 11;114(4):540-552. doi: 10.1093/jnci/djac004.
- PMID: 35048954
- PubMed abstract
Commentary:
Oral Contraceptives and BRCA Cancer: A Balancing Act.
- PMID: 35048983
- PubMed abstract
- Free Full Text
-
- Clinician-Reported Impact of Germline Multigene Panel Testing on Cancer Risk Management Recommendations.
- Horton C, Blanco K, Lo MT, Speare V, LaDuca H, Dolinsky JS, Kurian AW.
- JNCI Cancer Spectr. 2022 Mar 2;6(2):pkac002. doi: 10.1093/jncics/pkac002.
- PMID: 35603838
- PubMed abstract
-
- Hereditary Breast and Ovarian Cancer: An Updated Primer for OB/GYNs.
- Bellcross CA.
- Obstet Gynecol Clin North Am. 2022 Mar;49(1):117-147. doi: 10.1016/j.ogc.2021.11.005.
- PMID: 35168766
- PubMed abstract
- Source abstract
-
- US Bill Seeks to Expand Access to Genetic Cancer Testing for Medicare Members.
- [No author given]
- Inside Precision Medicine. Topics. Oncology. 2022 Feb 23.
- News
- Free Full Text
-
- Senate Bill Proposes to Expand Medicare Coverage for Hereditary Cancer Testing.
- [No author given]
- GenomeWeb. Disease Areas. Cancer. 2022 Feb 17.
- News
- Free Full Text
-
- Earlier decisions on breast and ovarian surgery reduce cancer in women at high risk.
- Saul H, Gursul D, Cassidy S, Evans G.
- BMJ. 2022 Feb 15;376:o258. doi: 10.1136/bmj.o258.
- PMID: 35168943
- PubMed abstract
- Source abstract
Original research:
Uptake and efficacy of bilateral risk reducing surgery in unaffected female BRCA1 and BRCA2 carriers.
- PMID: 33568438
- PubMed abstract
- Source abstract
-
- Uptake and efficacy of bilateral risk reducing surgery in unaffected female BRCA1 and BRCA2 carriers.
- Marcinkute R, Woodward ER, Gandhi A, Howell S, Crosbie EJ, Wissely J, Harvey J, Highton L, Murphy J, Holland C, Edmondson R, Clayton R, Barr L, Harkness EF, Howell A, Lalloo F, Evans DG.
- J Med Genet. 2022 Feb;59(2):133-140. doi: 10.1136/jmedgenet-2020-107356. Epub 2021 Feb 10.
- PMID: 33568438
- PubMed abstract
- Source abstract
Research news:
Earlier decisions on breast and ovarian surgery reduce cancer in women at high risk.
- PMID: 35168943
- PubMed abstract
- Source abstract
-
- Study Seeks to Prevent Cancer and Extend Quality of Life for Women at Increased Genetic Risk of Ovarian Cancer.
- Jenks S.
- FORCE. Blog. 2021 Oct 12.
- Blog post
- Free Full Text
-
- Evaluation of a patient decision aid for BRCA1/2 pathogenic variant carriers choosing an ovarian cancer prevention strategy.
- Steenbeek MP, van Bommel MHD, Harmsen MG, Hoogerbrugge N, van Doorn HC, Keurentjes JHM, van Beurden M, Zweemer RP, Gaarenstroom KN, Penders CGJ, Brood-van Zanten MMA, Vos MC, Piek JM, van Lonkhuijzen LRCW, Apperloo MJA, Coppus SFPJ, IntHout J, de Hullu JA, Hermens RPMG.
- Gynecol Oncol. 2021 Aug 26:S0090-8258(21)01317-2. doi: 10.1016/j.ygyno.2021.08.019. Epub ahead of print.
- PMID: 34456057
- PubMed abstract
-
- Attitudes toward Risk-Reducing Mastectomy and Risk-Reducing Salpingo-oophorectomy among Young, Unmarried, Healthy Women in Korea.
- Park B, Kim D, Kim J, Lee BY, Yoon J, Kim SW.
- Cancer Res Treat. 2021 Aug 9. doi: 10.4143/crt.2021.449. Epub ahead of print.
- PMID: 34384016
- PubMed abstract
- Source abstract
-
- Follow-up of tissue genomics in BRCA1/2 carriers who underwent prophylactic surgeries.
- Kotoula V, Papadopoulou K, Tikas I, Fostira F, Vrettou E, Chrisafi S, Fountzilas E, Koliou GA, Apostolou P, Papazisis K, Zaramboukas T, Asimaki-Vlachopoulou A, Miliaras S, Ananiadis A, Poulios C, Natsiopoulos I, Tsiftsoglou A, Demiri E, Fountzilas G.
- Breast Cancer. 2021 Jul 24. doi: 10.1007/s12282-021-01276-3. Epub ahead of print.
- PMID: 34304347
- PubMed abstract
- Source abstract
-
- BRCA, breast cancer and in vitro fertilization: How should we advise our patients?
- García-Planells J, Francés BS, Diez-Juan A.
- Fertil Steril. 2021 Jul 8:S0015-0282(21)00505-7. doi: 10.1016/j.fertnstert.2021.06.011. Epub ahead of print.
- PMID: 34247761
- PubMed abstract
- Commentary
- Free Full Text
Original research:
Fertility treatments and breast cancer risk in Jewish Israeli BRCA mutation carriers.
- PMID: 33823990
- PubMed abstract
- Source abstract
-
- Differences in Ovarian and Other Cancers Risks by Population and BRCA Mutation Location.
- Sekine M, Nishino K, Enomoto T.
- Genes (Basel). 2021 Jul 8;12(7):1050. doi: 10.3390/genes12071050.
- PMID: 34356066
- PubMed abstract
- Source abstract
- Review
- Free PMC article
- Free Full Text
-
- A competing risks model with binary time varying covariates for estimation of breast cancer risks in BRCA1 families.
- Briollais L.
- Stat Methods Med Res. 2021 Jul 7:9622802211008945. doi: 10.1177/09622802211008945. Epub ahead of print.
- PMID: 34232831
- PubMed abstract
-
- Genetic testing and surgical treatment after breast cancer diagnosis: Results from a national online cohort.
- Verdial FC, Bartek MA, Anderson BO, Javid SH.
- J Surg Oncol. 2021 Jun;123(7):1504-1512. doi: 10.1002/jso.26372. Epub 2021 Mar 18.
- PMID: 33735483
- PubMed abstract
- Source abstract
-
- Risk-Reducing Mastectomy and Reconstruction Following Prophylactic Breast Irradiation: Hope Sustained.
- Ben David MA, Evron E, Rasco AF, Shai A, Corn BW.
- Cancers (Basel). 2021 May 30;13(11):2694. doi: 10.3390/cancers13112694.
- PMID: 34070748
- PubMed abstract
- Source abstract
-
- A Clinical Trial of Prophylactic Prostatectomy for BRCA2 Mutation Carriers: Is Now the Time?
- Clark R, McAlpine K, Fleshner N.
- Eur Urol Focus. 2021 May;7(3):506-507. doi: 10.1016/j.euf.2021.04.018. Epub 2021 May 11.
- PMID: 33994169
- PubMed abstract
- Source abstract
-
- Management of patients with BRCA mutation from the point of view of a breast surgeon.
- Riis ML.
- Ann Med Surg (Lond). 2021 Apr 16;65:102311. doi: 10.1016/j.amsu.2021.102311.
- PMID: 33996049
- PubMed abstract
- Review
- Free PMC article
- Free Full Text
-
- Controversies in Hereditary Cancer Management.
- AlHilli MM, Pederson HJ.
- Obstet Gynecol. 2021 Apr 8. doi: 10.1097/AOG.0000000000004364. Epub ahead of print.
- PMID: 33831930
- PubMed abstract
- Source abstract
-
- Genetic Testing Challenges in Oncology: Forged Genetic Test Report Leads to Incorrect Management.
- Ray T.
- Precision Oncology News. Diagnostics. 2021 Mar 1.
- Press
- Free Full Text
-
- Prophylactic Surgery in the BRCA+ Patient: Do Women Develop Breast Cancer While Waiting?
- Macadam SA, Slater K, Cheifetz RE, Jansen L, Chia S, Brasher PMA, Bovill ES.
- Curr Oncol. 2021 Jan 25;28(1):702-715. doi: 10.3390/curroncol28010069.
- PMID: 33504079
- PubMed abstract
- Source abstract
-
- Challenges and Considerations on Risk-Reducing Surgery in BRCA1/2 Patients with Advanced Breast Cancer.
- Vasconcelos de Matos L, Fernandes L, Louro P, Plácido A, Barros M, Vaz F.
- Curr Oncol. 2021 Jan 14;28(1):485-490. doi: 10.3390/curroncol28010050.
- PMID: 33466630
- PubMed abstract
- Source abstract
- Case report
- Free Full Text
-
- Women's Intentions to Engage in Risk-Reducing Behaviours after Receiving Personal Ovarian Cancer Risk Information: An Experimental Survey Study.
- Gallagher A, Waller J, Manchanda R, Jacobs I, Sanderson S.
- Cancers (Basel). 2020 Nov 27;12(12):3543. doi: 10.3390/cancers12123543.
- PMID: 33260928
- PubMed abstract
- Source abstract
-
- Concurrent Prophylactic Mastectomy, Immediate Reconstruction, and Salpingo-Oophorectomy in High-Risk Patients: A Case Series.
- D'Abbondanza JA, George R, Kives S, Musgrave MA.
- Plast Surg (Oakv). 2020 Nov;28(4):243-248. doi: 10.1177/2292550320928551. Epub 2020 Jun 4.
- PMID: 33215039
- PubMed abstract
- Source abstract
-
- Surgical and Systemic Treatment of Hereditary Breast Cancer: A Mini-Review With a Focus on BRCA1 and BRCA2 Mutations.
- Pouptsis A, Swafe L, Patwardhan M, Stavraka C.
- Front Oncol. 2020 Oct 20;10:553080. doi: 10.3389/fonc.2020.553080. PMID: 33194613; PMCID: PMC7607003.
- PMID: 33194613
- PubMed abstract
- Review
- Free PMC article
- Free Full Text
-
- Hereditary breast and ovarian cancer (HBOC): review of its molecular characteristics, screening, treatment, and prognosis.
- Yoshida R.
- Breast Cancer. 2020 Aug 29. doi: 10.1007/s12282-020-01148-2. Epub ahead of print.
- PMID: 32862296
- PubMed abstract
- Review
- Free Full Text
-
- Management of breast cancer risk in BRCA1/2 mutation carriers who are unaffected with cancer.
- Collins JM, Isaacs C.
- Breast J. 2020 Jul 11. doi: 10.1111/tbj.13970. Epub ahead of print.
- PMID: 32652823
- PubMed abstract
- Source abstract
-
- Cancer Surveillance in Healthy Carriers of Germline Pathogenic Variants in BRCA1/2: A Review of Secondary Prevention Guidelines.
- Dullens B, de Putter R, Lambertini M, Toss A, Han S, Van Nieuwenhuysen E, Van Gorp T, Vanderstichele A, Van Ongeval C, Keupers M, Prevos R, Celis V, Dekervel J, Everaerts W, Wildiers H, Nevelsteen I, Neven P, Timmerman D, Smeets A, Denayer E, Van Buggenhout G, Legius E, Punie K.
- J Oncol. 2020 Jun 20;2020:9873954. doi: 10.1155/2020/9873954.
- PMID: 32655641
- PubMed abstract
- Review
- Free PMC article
- Free Full Text
-
- Factors Impacting on Decision-Making towards Prophylactic Surgeries in BRCA Mutation Carriers and Women with Familial Predisposition.
- Segerer R, Peschel C, Kämmerer U, Häussler S, Wöckel A, Segerer S.
- Breast Care (Basel). 2020 Jun;15(3):253-259. doi: 10.1159/000503370. Epub 2019 Oct 1.
- PMID: 32774219
- PubMed abstract
- Source abstract
-
- Risk Management for BRCA1/BRCA2 mutation carriers without and with breast cancer.
- Mainor CB, Isaacs C.
- Curr Breast Cancer Rep. 2020 Jun;12(2):66-74. doi: 10.1007/s12609-019-00350-2. Epub 2020 Feb 17.
- PMID: 33552388
- PubMed abstract
- Source abstract
-
- Executive Summary of the Early-Onset Breast Cancer Evidence Review Conference.
- Chelmow D, Pearlman MD, Young A, Bozzuto L, Dayaratna S, Jeudy M, Kremer ME, Scott DM, O'Hara JS.
- Obstet Gynecol. 2020 Jun;135(6):1457-1478. doi: 10.1097/AOG.0000000000003889.
- PMID: 32459439
- PubMed abstract
- Executive Summary, Review
- Free Full Text
-
- Canadian cost-effectiveness model of BRCA-driven surgical prevention of breast/ovarian cancers compared to treatment if cancer develops.
- Hurry M, Eccleston A, Dyer M, Hoskins P
- Int J Technol Assess Health Care. 2020 Apr;36(2):104-112. doi: 10.1017/S0266462319003519.
- PMID: 32423520
- PubMed abstract
- Source abstract
-
- Future Research Suggestions for Multigene Testing in Unselected Populations.
- Jun I, Berger AL, Yaghjyan L.
- JAMA Oncol. 2020 Mar 26. doi: 10.1001/jamaoncol.2020.0128. [Epub ahead of print]
- PMID: 32215575
- PubMed abstract
- Source abstract
Original research:
A Cost-effectiveness Analysis of Multigene Testing for All Patients With Breast Cancer.
- PMID: 31580391
- PubMed abstract
- Free full text
Letter, Reply:
Future Research Suggestions for Multigene Testing in Unselected Populations-Reply.
- PMID: 32215580
- PubMed abstract
- Source abstract
-
- Updated Guideline Moves Genetic Testing Beyond BRCA.
- Narozniak R.
- OncologyLive. 2020 Mar 13;21(6).
Guidelines:
Risk Assessment, Genetic Counseling, and Genetic Testing for BRCA-Related Cancer: US Preventive Services Task Force Recommendation Statement.
- PMID: 31429903
- PubMed abstract
- Free full text
-
- Experts say more women should be tested for BRCA1 and BRCA2 genetic mutations.
- Printz C.
- Cancer. 2020 Feb 15;126(4):693. doi: 10.1002/cncr.32723.
- PMID: 31995244
- PubMed abstract
- News
- Free full text
Guidelines:
Risk Assessment, Genetic Counseling, and Genetic Testing for BRCA-Related Cancer: US Preventive Services Task Force Recommendation Statement.
- PMID: 31429903
- PubMed abstract
- Free full text
-
- SEOM clinical guidelines in hereditary breast and ovarian cancer (2019).
- González-Santiago S, Ramón Y Cajal T, Aguirre E, Alés-Martínez JE, Andrés R, Balmaña J, Graña B, Herrero A, Llort G, González-Del-Alba A; SEOM Hereditary Cancer Working Group.
- Clin Transl Oncol. 2019 Dec 30. doi: 10.1007/s12094-019-02262-0. [Epub ahead of print]
- PMID: 31889241
- PubMed abstract
- Guidelines
- Free Full Text
-
- A Genetic Test Led Seven Women in One Family to Have Major Surgery. Then the Odds Changed.
- Marcus AD.
- The Wall Street Journal. 2019 Dec 20.
Press: Downgraded Variant. (GenomeWeb)
-
- Impact of Genetic Testing on Risk-Management Behavior of Black Breast Cancer Survivors: A Longitudinal, Observational Study.
- Conley CC, Kasting ML, Augusto BM, Garcia JD, Cragun D, Gonzalez BD, Kim J, Ashing KT, Knott CL, Hughes-Halbert C, Pal T, Vadaparampil ST.
- Ann Surg Oncol. 2019 Nov 1. doi: 10.1245/s10434-019-07982-9. [Epub ahead of print]
- PMID: 31677107
- PubMed abstract
- Source abstract
-
- Familial breast cancer: classification, care and managing breast cancer and related risks in people with a family history of breast cancer.
- [No author given]
- National Institute for Health and Care Excellence (UK): Clinical Guidelines; 2013 Jun. [Last Update: November 2019.]
- PMID: 31940157
- PubMed abstract
- Guidelines
- Free Full Text
-
- Interventions to improve psychosocial well-being in female BRCA-mutation carriers following risk-reducing surgery.
- Jeffers L, Reid J, Fitzsimons D, Morrison PJ, Dempster M.
- Cochrane Database Syst Rev. 2019 Oct 9;10:CD012894. doi: 10.1002/14651858.CD012894.pub2. [Epub ahead of print]
- PMID: 31595976
- PubMed abstract
- Source abstract
Original research:
Mindfulness-based stress reduction for menopausal symptoms after risk-reducing salpingo-oophorectomy (PURSUE study): a randomised controlled trial.
- PMID: 30222235
- PubMed abstract
- Free Full Text
Original research:
Addressing sexual dysfunction after risk-reducing salpingo-oophorectomy: effects of a brief, psychosexual intervention.
- PMID: 25311333
- PubMed abstract
- Free Full Text
-
- A Cost-effectiveness Analysis of Multigene Testing for All Patients With Breast Cancer.
- Sun L, Brentnall A, Patel S, Buist DSM, Bowles EJA, Evans DGR, Eccles D, Hopper J, Li S, Southey M, Duffy S, Cuzick J, Dos Santos Silva I, Miners A, Sadique Z, Yang L, Legood R, Manchanda R.
- JAMA Oncol. 2019 Oct 3. doi: 10.1001/jamaoncol.2019.3323. [Epub ahead of print]
- PMID: 31580391
- PubMed abstract
CME Audio Interview: Cost-effectiveness of Multigene Testing for All Patients With Breast Cancer. (JN Learning : JAMA Oncology)
Press: Study Finds Breast, Ovarian Cancer Gene Tests Cost-Effective for Unselected Breast Cancer Patients. (GenomeWeb)
Letter, Comment:
Future Research Suggestions for Multigene Testing in Unselected Populations.
- PMID: 32215575
- PubMed abstract
- Source abstract
Letter, Reply:
Future Research Suggestions for Multigene Testing in Unselected Populations—Reply.
- PMID: 32215580
- PubMed abstract
- Source abstract
-
- Broad Application of Multigene Panel Testing for Breast Cancer Susceptibility-Pandora's Box Is Opening Wider.
- Robson M, Domchek S.
- JAMA Oncol. 2019 Oct 3. doi: 10.1001/jamaoncol.2019.4004. [Epub ahead of print]
- PMID: 31580388
- PubMed abstract
- Source abstract
-
- Cost effectiveness of bilateral risk-reducing mastectomy and salpingo-oophorectomy.
- Schrauder MG, Brunel-Geuder L, Häberle L, Wunderle M, Hoyer J, Csorba R, Reis A, Schulz-Wendtland R, Beckmann MW, Lux MP.
- Eur J Med Res. 2019 Sep 14;24(1):32. doi: 10.1186/s40001-019-0391-8.
- PMID: 31521205
- PubMed abstract
-
- Risk Assessment, Genetic Counseling, and Genetic Testing for BRCA-Related Cancer: US Preventive Services Task Force Recommendation Statement.
- US Preventive Services Task Force, Owens DK, Davidson KW, Krist AH, Barry MJ, Cabana M, Caughey AB, Doubeni CA, Epling JW Jr, Kubik M, Landefeld CS, Mangione CM, Pbert L, Silverstein M, Simon MA, Tseng CW, Wong JB.
- JAMA. 2019 Aug 20;322(7):652-665. doi: 10.1001/jama.2019.10987.
- PMID: 31429903
- PubMed abstract
- Guidelines
- Free Full Text
Evidence report, Review:
Risk Assessment, Genetic Counseling, and Genetic Testing for BRCA-Related Cancer in Women: Updated Evidence Report and Systematic Review for the US Preventive Services Task Force.
- PMID: 31429902
- PubMed abstract
- Free Full Text
Guidelines [Internet]:
Risk Assessment, Genetic Counseling, and Genetic Testing for BRCA1/2-Related Cancer in Women: A Systematic Review for the U.S. Preventive Services Task Force [Internet].
- PMID: 31479213
- PubMed abstract
- Free Full Text
Editorial:
Broadening Criteria for BRCA1/2 Evaluation: Placing the USPSTF Recommendation in Context.
- PMID: 31429878
- PubMed abstract
- Source abstract
Editorial:
USPSTF Recommendations for BRCA1 and BRCA2 Testing in the Context of a Transformative National Cancer Control Plan.
- PMID: 31429910
- PubMed abstract
- Free Full Text
Editorial:
Hereditary Cancer Evaluation in 2019-a Rapidly Evolving Landscape.
- PMID: 31429864
- PubMed abstract
- Source abstract
Editorial:
US Preventive Services Task Force Breast Cancer Recommendation Statement on Risk Assessment, Genetic Counseling, and Genetic Testing for BRCA-Related Cancer.
- PMID: 31429868
- PubMed abstract
- Source abstract
News:
USPSTF Calls for More BRCA Screening.
- PMID: 31527132
- PubMed abstract
- Source abstract
Patient Page:
Should I Be Tested for BRCA Mutations?
- PMID: 31429898
- PubMed abstract
- Free Full Text
Audio Interview, CME Activity: USPSTF Recommendation: Assessment, Counseling, and Testing for BRCA-Related Cancer. (JAMA)
Press: USPSTF Recommendations on BRCA Mutation Testing. (Medscape Oncology)
-
- Risk Assessment, Genetic Counseling, and Genetic Testing for BRCA-Related Cancer in Women: Updated Evidence Report and Systematic Review for the US Preventive Services Task Force.
- Nelson HD, Pappas M, Cantor A, Haney E, Holmes R.
- JAMA. 2019 Aug 20;322(7):666-685. doi: 10.1001/jama.2019.8430.
- PMID: 31429902
- PubMed abstract
- Guidelines
- Free Full Text
Guidelines:
Risk Assessment, Genetic Counseling, and Genetic Testing for BRCA-Related Cancer: US Preventive Services Task Force Recommendation Statement.
- PMID: 31429903
- PubMed abstract
- Free Full Text
Guidelines:
Risk Assessment, Genetic Counseling, and Genetic Testing for BRCA1/2-Related Cancer in Women: A Systematic Review for the U.S. Preventive Services Task Force [Internet].
- PMID: 31479213
- PubMed abstract
- Free Full Text
-
- Should I Be Tested for BRCA Mutations?
- Jin J.
- JAMA. 2019 Aug 20;322(7):702. doi: 10.1001/jama.2019.11251.
- PMID: 31429898
- PubMed abstract
- Patient Page
- Free Full Text
Guidelines:
Risk Assessment, Genetic Counseling, and Genetic Testing for BRCA-Related Cancer: US Preventive Services Task Force Recommendation Statement.
- PMID: 31429903
- PubMed abstract
- Free Full Text
-
- USPSTF Recommendation: Assessment, Counseling, and Testing for BRCA-Related Cancer.
- Mangione CM.
- JAMA. 2019 Aug 20.
- Audio Interview, CME Activity
- Free Audio
Guidelines:
Risk Assessment, Genetic Counseling, and Genetic Testing for BRCA-Related Cancer: US Preventive Services Task Force Recommendation Statement.
- PMID: 31429903
- PubMed abstract
- Free Full Text
-
- Risk Assessment, Genetic Counseling, and Genetic Testing for BRCA1/2-Related Cancer in Women: A Systematic Review for the U.S. Preventive Services Task Force [Internet].
- Nelson HD, Pappas M, Cantor A, Haney E, Holmes R, Stillman L.
- Rockville (MD): Agency for Healthcare Research and Quality (US); 2019 Aug. Report No.: 19-05251-EF-1. U.S. Preventive Services Task Force Evidence Syntheses, formerly Systematic Evidence Reviews.
- PMID: 31479213
- PubMed abstract
- Source abstract
- Guidelines
- Free Full Text
Guidelines:
Risk Assessment, Genetic Counseling, and Genetic Testing for BRCA-Related Cancer: US Preventive Services Task Force Recommendation Statement.
- PMID: 31429903
- PubMed abstract
- Free Full Text
Guidelines:
Risk Assessment, Genetic Counseling, and Genetic Testing for BRCA-Related Cancer in Women: Updated Evidence Report and Systematic Review for the US Preventive Services Task Force.
- PMID: 31429902
- PubMed abstract
- Free Full Text
-
- Screening and surgical prophylaxis for hereditary cancer syndromes with high risk of endometrial and ovarian cancer.
- Bercow AS, Eisenhauer EL.
- J Surg Oncol. 2019 Jul 29. doi: 10.1002/jso.25645. [Epub ahead of print]
- PMID: 31355450
- PubMed abstract
- Source abstract
-
- A young woman's story of genetic testing and risk-reducing mastectomy.
- [No author given]
- FORCE. XRAYS. 2019 Jun 6.
- Commentary
- Free Full Text
Narrative: I Had a Preventive Mastectomy—Then Found Out I Already Had Breast Cancer. (Health)
-
- [Recommendations for Preventive Care for Women with Rare Genetic Cause of Breast and Ovarian Cancer.]
- Foretová L, Navrátilová M, Svoboda M, Vašíčková P, Sťahlová EH, Házová J, Kleiblová P, Kleibl Z, Macháčková E, Palácová M, Petráková K.
- Klin Onkol. 2019 Summer;32(Supplementum2):6-13. doi: 10.14735/amko2019S6.
- PMID: 31409076
- PubMed abstract
- Source abstract
- Review, [Article in Czech], English Abstract
- Free Full Text - Czech (PDF)
-
- Cancer Genomics for Oncologists: Cancer Risk and Management of BRCA1 and BRCA2 Carriers.
- George A.
- Curr Genet Med Rep. 2019 Jun;7(2):116-123. doi: 10.1007/s40142-019-00167-6. Epub 2019 May 9.
-
- Five screening-detected breast cancer cases in initially disease-free BRCA1 or BRCA2 mutation carriers.
- Shimada S, Yoshida R, Nakashima E, Kitagawa D, Gomi N, Horii R, Takeuchi S, Ashihara Y, Kita M, Akiyama F, Ohno S, Saito M, Arai M.
- Breast Cancer. 2019 Apr 12. doi: 10.1007/s12282-019-00971-6. [Epub ahead of print]
- PMID: 30980249
- PubMed abstract
- Case report
- Free Full Text
-
- Economic modeling of risk-adapted screen-and-treat strategies in women at high risk for breast or ovarian cancer.
- Müller D, Danner M, Schmutzler R, Engel C, Wassermann K, Stollenwerk B, Stock S, Rhiem K.
- Eur J Health Econ. 2019 Feb 21. doi: 10.1007/s10198-019-01038-1. [Epub ahead of print]
- PMID: 30790097
- PubMed abstract
- Source abstract
-
- Optimise not compromise: The importance of a multidisciplinary breast cancer patient pathway in the era of oncoplastic and reconstructive surgery.
- Strach MC, Prasanna T, Kirova YM, Alran S, O'Toole S, Beith JM, Poortmans P, McNeil CM, Carroll S.
- Crit Rev Oncol Hematol. 2019 Feb;134:10-21. doi: 10.1016/j.critrevonc.2018.11.007. Epub 2018 Nov 30.
- PMID: 30771869
- PubMed abstract
- Source abstract
-
- Selected medical interventions in women with a deleterious BRCA mutation: a population-based study in British Columbia.
- Hanley GE, McAlpine JN, Cheifetz R, Schrader KA, McCullum M, Huntsman D.
- Curr Oncol. 2019 Feb;26(1):e17-e23. doi: 10.3747/co.26.4068. Epub 2019 Feb 1.
- PMID: 30853805
- PubMed abstract
- Source abstract
-
- Perioperative Management of Women Undergoing Risk-reducing Surgery for Hereditary Breast and Ovarian Cancer.
- AlHilli MM, Al-Hilli Z.
- J Minim Invasive Gynecol. 2019 Feb;26(2):253-265. doi: 10.1016/j.jmig.2018.09.767. Epub 2018 Sep 19.
- PMID: 30240898
- PubMed abstract
- Source abstract
-
- Bilateral prophylactic mastectomy in BRCA mutation carriers: what surgeons need to know.
- Franceschini G, Di Leone A, Terribile D, Sanchez MA, Masetti R.
- Ann Ital Chir. 2019;90:1-2.
- PMID: 30872561
- PubMed abstract
-
- No. 366-Gynaecologic Management of Hereditary Breast and Ovarian Cancer.
- Jacobson M, Bernardini M, Sobel ML, Kim RH, McCuaig J, Allen L.
- J Obstet Gynaecol Can. 2018 Nov;40(11):1497-1510. doi: 10.1016/j.jogc.2018.05.046.
- PMID: 30473125
- PubMed abstract
- Source abstract
[Article in French]:
No 366 - Prise en charge gynécologique du cancer du sein et de l'ovaire héréditaire.
- PMID: 30473126
- PubMed abstract
- Source abstract
-
- Risk-Reducing Options for Women with a Hereditary Breast Cancer Predisposition.
- Jatoi I.
- Eur J Breast Health. 2018 Oct 1;14(4):189-193. doi: 10.5152/ejbh.2018.4324. eCollection 2018 Oct.
- PMID: 30288491
- PubMed abstract
- Source abstract
Letter, Review:
What The Surgeons Should Know About The Bilateral Prophylactic Mastectomy in BRCA Mutation Carriers.
- PMID: 31001617
- PubMed abstract
- Source abstract
-
- Germline and somatic genetic testing in ovarian cancer patients.
- Chandrasekaran D, Manchanda R.
- BJOG. 2018 Oct;125(11):1460. doi: 10.1111/1471-0528.15225. Epub 2018 May 10.
- PMID: 29577554
- PubMed abstract
- Source abstract
-
- Surgery for BRCA, TP53 and PALB2: a literature review.
- Song CV, Teo SH, Taib NA, Yip CH.
- Ecancermedicalscience. 2018 Aug 29;12:863. doi: 10.3332/ecancer.2018.863. eCollection 2018.
- PMID: 30174725
- PubMed abstract
- Source abstract
- Review
- Free PMC article
- Free Full Text
-
- Breast Cancer Surgical Risk Reduction for Patients With Inherited Mutations in Moderate Penetrance Genes.
- Weiss A, Garber JE, King T.
- JAMA Surg. 2018 Aug 29. doi: 10.1001/jamasurg.2018.2493. [Epub ahead of print]
- PMID: 30167656
- PubMed abstract
- Source abstract
-
- Concurrent risk-reduction surgery in patients with increased lifetime risk for breast and ovarian cancer: an analysis of the National Surgical Quality Improvement Program (NSQIP) database.
- Elmi M, Azin A, Elnahas A, McCready DR, Cil TD.
- Breast Cancer Res Treat. 2018 Aug;171(1):217-223. doi: 10.1007/s10549-018-4818-7. Epub 2018 May 14.
- PMID: 29761322
- PubMed abstract
- Source abstract
-
- Reducing the Risk of Gynecologic Cancer in Hereditary Breast Ovarian Cancer Syndrome Mutation Carriers: Moral Dilemmas and the Principle of Double Effect.
- Casey MJ, Salzman TA.
- Linacre Q. 2018 Aug;85(3):225-240. doi: 10.1177/0024363918788340. Epub 2018 Jul 20.
- PMID: 30275608
- PubMed abstract
- Source abstract
-
- A multigene test could cost-effectively help extend life expectancy for women at risk of hereditary breast cancer-Reply to letter to the editor by Petelin et al.
- Li Y, Devlin JJ.
- Value Health. 2018 Jul;21(7):893-894. doi: 10.1016/j.jval.2018.02.010. Epub 2018 Apr 5.
- PMID: 30005763
- PubMed abstract
- Source abstract
Letter:
Heterogeneity and Uncertainties Specific to Genome-Based Health Technological Assessments.
- PMID: 30005762
- PubMed abstract
- Source abstract
Original Research:
A Multigene Test Could Cost-Effectively Help Extend Life Expectancy for Women at Risk of Hereditary Breast Cancer.
- PMID: 28407996
- PubMed abstract
- Free Full Text
-
- BRCA Mutations in the Young, High-Risk Female Population: Genetic Testing, Management of Prophylactic Therapies, and Implications for Plastic Surgeons.
- Salibian AA, Frey JD, Choi M, Karp NS.
- Plast Reconstr Surg. 2018 Jun;141(6):1341-1350. doi: 10.1097/PRS.0000000000004363.
- PMID: 29794695
- PubMed abstract
-
- Cost-effectiveness of different strategies to prevent breast and ovarian cancer in German women with a BRCA 1 or 2 mutation.
- Müller D, Danner M, Rhiem K, Stollenwerk B, Engel C, Rasche L, Borsi L, Schmutzler R, Stock S.
- Eur J Health Econ. 2018 Apr;19(3):341-353. doi: 10.1007/s10198-017-0887-5. Epub 2017 Apr 5.
- PMID: 28382503
- PubMed abstract
- Source abstract
-
- Germline & somatic genetic testing in ovarian cancer patients.
- Chandrasekaran D, Manchanda R.
- BJOG. 2018 Mar 25. doi: 10.1111/1471-0528.15225. [Epub ahead of print]
- PMID: 29577554
- PubMed abstract
- Source abstract
-
- Cost-effectiveness of surveillance and prevention strategies in BRCA1/2 mutation carriers.
- Yamauchi H, Nakagawa C, Kobayashi M, Kobayashi Y, Mano T, Nakamura S, Arai M.
- Breast Cancer. 2018 Mar;25(2):141-150. doi: 10.1007/s12282-017-0803-y. Epub 2017 Oct 10.
- PMID: 29019095
- PubMed abstract
- Source abstract
-
- Recommendations and Choices for BRCA Mutation Carriers at Risk for Ovarian Cancer: A Complicated Decision.
- Lewis KE, Lu KH, Klimczak AM, Mok SC.
- Cancers (Basel). 2018 Feb 21;10(2). pii: E57. doi: 10.3390/cancers10020057.
- PMID: 29466291
- PubMed abstract
- Source abstract
- Review
- Free Full Text (PDF)
-
- Management of hereditary breast and ovarian cancer.
- Yamauchi H, Takei J.
- Int J Clin Oncol. 2018 Feb;23(1):45-51. doi: 10.1007/s10147-017-1208-9. Epub 2017 Nov 28.
- PMID: 29185095
- PubMed abstract
- Source abstract
-
- Considerations in Testing for Inherited Breast Cancer Predisposition in the Era of Personalized Medicine.
- Powers B, Pal T, Laronga C.
- Surg Oncol Clin N Am. 2018 Jan;27(1):1-22. doi: 10.1016/j.soc.2017.08.003.
- PMID: 29132555
- PubMed abstract
- Source abstract
-
- Prophylactic Surgery: For Whom, When and How?
- Mau C, Untch M.
- Breast Care (Basel). 2017 Dec;12(6):379-384. doi: 10.1159/000485830. Epub 2017 Dec 13.
- PMID: 29456469
- PubMed abstract
- Source abstract
- Review
- Free PMC article
- Free Full Text
-
- Non-BRCA1/2 Breast Cancer Susceptibility Genes: A New Frontier with Clinical Consequences for Plastic Surgeons.
- Frey JD, Salibian AA, Schnabel FR, Choi M, Karp NS.
- Plast Reconstr Surg Glob Open. 2017 Nov 20;5(11):e1564. doi: 10.1097/GOX.0000000000001564. eCollection 2017 Nov.
- PMID: 29263966
- PubMed abstract
- Review
- Free PMC article
- Free Full Text
-
- Sexual Health Is Paramount in the Counseling of Women at Risk for Breast or Ovarian Cancer Undergoing Risk-Reducing Surgery.
- Rullo JE, Pruthi S.
- J Natl Compr Canc Netw. 2017 Nov 1;15(11):1297. doi: 10.6004/jnccn.2017.7016.
-
- Current and future role of genetic screening in gynecologic malignancies.
- Ring KL, Garcia C, Thomas MH, Modesitt SC.
- Am J Obstet Gynecol. 2017 Nov;217(5):512-521. doi: 10.1016/j.ajog.2017.04.011. Epub 2017 Apr 12.
- PMID: 28411145
- PubMed abstract
- Source abstract
- Review
- Free Full Text
-
- What about prophylactic surgery in BRCA1/BRCA2 mutation carriers? Observations from an Italian pilot study.
- Dionigi F, Maffoni M, Ferrari A, Garcia-Etienne CA, Ricciardi A, Razzaboni E, Sgarella A, Trotti E.
- Breast J. 2017 Nov;23(6):766-767. doi: 10.1111/tbj.12825. Epub 2017 Jun 2.
- PMID: 28574632
- PubMed abstract
- Source abstract
-
- Integrating surgery and genetic testing for the modern surgeon.
- Caso R, Beamer M, Lofthus AD, Sosin M.
- Ann Transl Med. 2017 Oct;5(20):399. doi: 10.21037/atm.2017.06.50.
- PMID: 29152499
- PubMed abstract
- Source abstract
- Review
- Free PMC article
- Free Full Text
-
- Risk of uterine cancer for BRCA1 and BRCA2 mutation carriers.
- Lee YC, Milne RL, Lheureux S, Friedlander M, McLachlan SA, Martin KL, Bernardini MQ, Smith C, Picken S, Nesci S, Hopper JL, Phillips KA; Kathleen Cuningham Foundation Consortium for Research into Familial Breast Cancer (kConFab).
- Eur J Cancer. 2017 Oct;84:114-120. doi: 10.1016/j.ejca.2017.07.004. Epub 2017 Aug 10.
- PMID: 28802188
- PubMed abstract
- Source abstract
-
- Risk Reduction Strategies in Breast Cancer Prevention.
- Costa M, Saldanha P.
- Eur J Breast Health. 2017 Jul 1;13(3):103-112. doi: 10.5152/ejbh.2017.3583. eCollection 2017 Jul.
- PMID: 28894848
- PubMed abstract
- Source abstract
- Review
- Free Full Text (PDF)
-
- Practice Patterns of Hereditary Ovarian Cancer Management in Korea.
- Choi MC, Lim MC, Lee M, Kim MK, Suh DH, Song YJ, Kim TJ, Chang SJ, Kim JW.
- Int J Gynecol Cancer. 2017 May 12. doi: 10.1097/IGC.0000000000000964. [Epub ahead of print]
- PMID: 28498247
- PubMed abstract
- Source abstract
-
- Cost-effectiveness of risk-reducing surgeries in preventing hereditary breast and ovarian cancer.
- Schrauder MG, Brunel-Geuder L, Häberle L, Wunderle M, Hoyer J, Reis A, Schulz-Wendtland R, Beckmann MW, Lux MP.
- Breast. 2017 Apr;32:186-191. doi: 10.1016/j.breast.2017.02.008. Epub 2017 Feb 17.
- PMID: 28214786
- PubMed abstract
- Source abstract
-
- A Multigene Test Could Cost-Effectively Help Extend Life Expectancy for Women at Risk of Hereditary Breast Cancer.
- Li Y, Arellano AR, Bare LA, Bender RA, Strom CM, Devlin JJ.
- Value Health. 2017 Apr;20(4):547-555. doi: 10.1016/j.jval.2017.01.006. Epub 2017 Feb 23.
- PMID: 28407996
- PubMed abstract
- Source abstract
- Free Full Text
News: Advantage of Multigene Test for Women at Risk of Hereditary Breast Cancer. (OncoTherapy Network)
Letter:
Heterogeneity and Uncertainties Specific to Genome-Based Health Technological Assessments.
- PMID: 30005762
- PubMed abstract
- Source abstract
Letter:
A multigene test could cost-effectively help extend life expectancy for women at risk of hereditary breast cancer-Reply to letter to the editor by Petelin et al.
- PMID: 30005763
- PubMed abstract
- Source abstract
-
- A Cost-Effectiveness Evaluation of Germline BRCA1 and BRCA2 Testing in UK Women with Ovarian Cancer.
- Eccleston A, Bentley A, Dyer M, Strydom A, Vereecken W, George A, Rahman N.
- Value Health. 2017 Apr;20(4):567-576. doi: 10.1016/j.jval.2017.01.004. Epub 2017 Mar 3.
- PMID: 28407998
- PubMed abstract
- Source abstract
-
- A brother and sister with breast cancer, BRCA2 mutations and bilateral supernumerary nipples.
- McKay M, Coad R.
- Ann Transl Med. 2017 Mar;5(5):106. doi: 10.21037/atm.2017.03.02.
- PMID: 28361071
- PubMed abstract
- Source abstract
- Case report
- Free PMC article
- Free Full Text
-
- BRCA mutation genetic testing implications in the United States.
- Bayraktar S, Arun B.
- Breast. 2017 Feb;31:224-232. doi: 10.1016/j.breast.2016.11.021. Epub 2016 Dec 6.
- PMID: 27931006
- PubMed abstract
- Source abstract
- Review
- Free Full Text
-
- Outcomes of Concurrent Breast and Gynecologic Risk Reduction Surgery.
- Ma IT, Gray RJ, Wasif N, Butler KA, Cornella JL, Magrina JF, Magtibay PM, Casey WJ, Mahabir R, Rebecca AM, Hunt KS, Pockaj BA.
- Ann Surg Oncol. 2017 Jan;24(1):77-83. doi: 10.1245/s10434-016-5479-6. Epub 2016 Aug 31.
- PMID: 27581610
- PubMed abstract
- Source abstract
-
- The effect of referral for genetic counseling on genetic testing and surgical prevention in women at high risk for ovarian cancer: Results from a randomized controlled trial.
- Drescher CW, Beatty JD, Resta R, Andersen MR, Watabayashi K, Thorpe J, Hawley S, Purkey H, Chubak J, Hanson N, Buist DSM, Urban N.
- Cancer. 2016 Nov 15;122(22):3509-3518. doi: 10.1002/cncr.30190. Epub 2016 Jul 22.
- PMID: 27447168
- PubMed abstract
- Source abstract
-
- Risk reduction and survival benefit of prophylactic surgery in BRCA mutation carriers, a systematic review.
- Ludwig KK, Neuner J, Butler A, Geurts JL, Kong AL.
- Am J Surg. 2016 Oct;212(4):660-669. doi: 10.1016/j.amjsurg.2016.06.010. Epub 2016 Jul 18.
- PMID: 27649974
- PubMed abstract
- Source abstract
-
- Identification and management of women with a family history of breast cancer: Practical guide for clinicians.
- Heisey R, Carroll JC.
- Can Fam Physician. 2016 Oct;62(10):799-803.
- PMID: 27737975
- PubMed abstract
- Source abstract
- Review, Case report
- Free Full Text
-
- Management of women with a hereditary predisposition for breast cancer.
- Jatoi I, Benson JR.
- Future Oncol. 2016 Oct;12(19):2277-88. doi: 10.2217/fon-2016-0186. Epub 2016 Jul 7.
- PMID: 27384952
- PubMed abstract
- Source abstract
-
- Müllerian intra-abdominal carcinomatosis in hereditary breast ovarian cancer syndrome: implications for risk-reducing surgery.
- Casey MJ, Colanta AB.
- Fam Cancer. 2016 Jul;15(3):371-84. doi: 10.1007/s10689-016-9878-4.
- PMID: 26875157
- PubMed abstract
- Source abstract
-
- Women's Health Issues for BRCA Mutation Carriers.
- Sabatini ME, Ellisen LW.
- Am Soc Clin Oncol Educ Book. 2016 May;(36):14-17. doi: 10.1200/EDBK_100001.
- PMID: 30372331
- PubMed abstract
- Source abstract
- Review
- Free Full Text
-
- Podcast: Making Prophylactic Surgery Decisions.
- Ellen T. Matloff.
- My Gene Counsel. 2016 Feb 24.
- Blog post, Podcast
- Free Full Text
-
- The Role of Risk-Reducing Surgery in Hereditary Breast and Ovarian Cancer.
- Hartmann LC, Lindor NM.
- N Engl J Med. 2016 Feb 4;374(5):454-68. doi: 10.1056/NEJMra1503523.
- PMID: 26840135
- PubMed abstract
- Source abstract
Comment, Letter
Risk-Reducing Surgery in Hereditary Breast and Ovarian Cancer.
- PMID: 27305204
- PubMed abstract
- Free Full Text
Comment, Letter
Risk-Reducing Surgery in Hereditary Breast and Ovarian Cancer.
- PMID: 27305205
- PubMed abstract
- Free Full Text
Comment, Letter
Risk-Reducing Surgery in Hereditary Breast and Ovarian Cancer.
- PMID: 27305206
- PubMed abstract
- Free Full Text
News: Better Approaches to Patient Counseling of BRCA Gene Mutation Carriers Needed. (Oncology Nurse Advisor)
-
- Genetic/Familial High-Risk Assessment: Breast and Ovarian, Version 2.2015.
- Daly MB, Pilarski R, Axilbund JE, Berry M, Buys SS, Crawford B, Farmer M, Friedman S, Garber JE, Khan S, Klein C, Kohlmann W, Kurian A, Litton JK, Madlensky L, Marcom PK, Merajver SD, Offit K, Pal T, Rana H, Reiser G, Robson ME, Shannon KM, Swisher E, Voian NC, Weitzel JN, Whelan A, Wick MJ, Wiesner GL, Dwyer M, Kumar R, Darlow S.
- J Natl Compr Canc Netw. 2016 Feb;14(2):153-62.
- PMID: 26850485
- PubMed abstract
- Source abstract
Comments on NSGC Discussion Forum Cancer SIG
-
- Surgical Decision Making in the BRCA-Positive Population: Institutional Experience and Comparison with Recent Literature.
- Flippo-Morton T, Walsh K, Chambers K, Amacker-North L, White B, Sarantou T, Boselli DM, White RL Jr.
- Breast J. 2016 Jan-Feb;22(1):35-44. doi: 10.1111/tbj.12521. Epub 2015 Dec 23.
- PMID: 26695813
- PubMed abstract
- Source abstract
-
- Women's Health Issues for BRCA Mutation Carriers.
- Sabatini ME, Ellisen LW.
- Am Soc Clin Oncol Educ Book. 2016;35:14-17. doi: 10.14694/EDBK_100001.
- PMID: 27249681
- PubMed abstract
- Review
- Free Full Text
Comments from NSGC Discussion Forum Cancer SIG
-
- [Gynecological Care and Prevention of Gynecological Malignancies in BRCA1 and BRCA2 Mutation Carriers].
- Zikán M.
- Klin Onkol. 2015 Winter;29 Suppl 1:22-30.
- PMID: 26691939
- PubMed abstract
- Source abstract
-
- How medical choices influence quality of life of women carrying a BRCA mutation.
- Harmsen MG, Hermens RP, Prins JB, Hoogerbrugge N, de Hullu JA.
- Crit Rev Oncol Hematol. 2015 Dec;96(3):555-68. doi: 10.1016/j.critrevonc.2015.07.010. Epub 2015 Jul 26.
- PMID: 26299336
- PubMed abstract
- Source abstract
- Review
- Free Full Text
-
- Risk-reducing surgery in BRCA 1/2 mutation carries: a point of view.
- De Felice F, Marchetti C.
- Oncotarget. 2015 Nov 24;6(37):39391-2. doi: 10.18632/oncotarget.6348.
- PMID: 26588056
- PubMed abstract
- Source abstract
- Editorial / Commentary
- Free PMC article
- Free Full Text (PDF)
-
- The Genetics of Breast Cancer: What the Surgical Oncologist Needs to Know.
- Weitzel JN.
- Surg Oncol Clin N Am. 2015 Oct;24(4):705-732. doi: 10.1016/j.soc.2015.06.011.
- PMID: 26363538
- PubMed abstract
- Source abstract
-
- A Rare Case of BRCA2-Associated Breast Cancer in Pregnancy.
- Leidhin CN, Heeney A, Connolly C, Swan N, Foster A, Geraghty J.
- Ir Med J. 2015 Jul-Aug;108(7):217-8.
- PMID: 26349355
- PubMed abstract
- Case report
- Free Full Text
-
- Breast Cancer Risk Reduction, Version 2.2015.
- Bevers TB, Ward JH, Arun BK, Colditz GA, Cowan KH, Daly MB, Garber JE, Gemignani ML, Gradishar WJ, Jordan JA, Korde LA, Kounalakis N, Krontiras H, Kumar S, Kurian A, Laronga C, Layman RM, Loftus LS, Mahoney MC, Merajver SD, Meszoely IM, Mortimer J, Newman L, Pritchard E, Pruthi S, Seewaldt V, Specht MC, Visvanathan K, Wallace A, Bergman MA, Kumar R.
- J Natl Compr Canc Netw. 2015 Jul;13(7):880-915.
- PMID: 26150582
- PubMed abstract
- Source abstract
-
- Should risk-reducing surgery in women from hereditary breast ovarian cancer families be confined to removal of the fallopian tubes with ovarian conservation?
- Snyder CL, Casey MJ, Lynch HT.
- Womens Health (Lond Engl). 2015 Jul;11(4):423-7. doi: 10.2217/whe.15.26. Epub 2015 Aug 6.
- PMID: 26246179
- PubMed abstract
- Source abstract
-
- Recommendations and Reality: What Personal Stories of Hereditary Cancer Can Tell Us.
- Ridgely Fisk Green, Katrina Trivers.
- CDC. Genomics and Health Impact Blog. 2015 Jun 1.
- Blog post
- Free Full Text
-
- The Consequences of a BRCA Mutation in Women.
- Famorca-Tran J, Roux G.
- J Adv Pract Oncol. 2015 May-Jun;6(3):194-210. Epub 2015 May 1.
- PMID: 26557407
- PubMed abstract
- Source abstract
- Review
- Free PMC article
-
- Risk-reducing surgery in hereditary gynecological cancer: Clinical applications in Lynch syndrome and hereditary breast and ovarian cancer.
- Adachi M, Banno K, Yanokura M, Iida M, Nakamura K, Nogami Y, Umene K, Masuda K, Kisu I, Ueki A, Hirasawa A, Tominaga E, Aoki D.
- Mol Clin Oncol. 2015 Mar;3(2):267-273. Epub 2014 Nov 20.
- PMID: 25798252
- PubMed abstract
- Source abstract
- Review
- Free PMC article
- Free Full Text
-
- A comprehensive approach to the identification and management of the BRCA patient.
- Garcia C, Powell CB.
- Obstet Gynecol Surv. 2015 Feb;70(2):131-43. doi: 10.1097/OGX.0000000000000156.
- PMID: 25671374
- PubMed abstract
- Source abstract
-
- Hereditary cancer syndromes with high risk of endometrial and ovarian cancer: Surgical options for personalized care.
- McCann GA, Eisenhauer EL.
- J Surg Oncol. 2015 Jan;111(1):118-24. doi: 10.1002/jso.23743. Epub 2014 Aug 20.
- PMID: 25139656
- PubMed abstract
- Source abstract
-
- Breast Cancer Following Ovarian Cancer in BRCA Mutation Carriers.
- Gangi A, Cass I, Paik D, Barmparas G, Karlan B, Dang C, Li A, Walsh C, Rimel BJ, Amersi FF.
- JAMA Surg. 2014 Dec 1;149(12):1306-1313. doi: 10.1001/jamasurg.2014.1081.
- PMID: 25372568
- PubMed abstract
Comments on NSGC Discussion Forum Cancer SIG
Subject: Breast cancer risk in ovarian cancer survivors
Subject: BRCA+ ovarian ca dx- breast ca risk and outcomes
Letter
Effect of Breast Cancer After Ovarian Cancer on Mortality for BRCA Mutation Carriers.
- PMID: 25807333
- PubMed abstract
- Source abstract
Letter, Reply
Effect of Breast Cancer After Ovarian Cancer on Mortality for BRCA Mutation Carriers-Reply.
- PMID: 25807476
- PubMed abstract
- Source abstract
-
- BRCA genetic testing: State of the science.
- Kelly PA, Connors LM.
- Nurse Pract. 2014 Nov 16;39(11):9. doi: 10.1097/01.NPR.0000456025.48460.c5.
- PMID: 25325521
- PubMed abstract
- Source abstract
Review:
Genetic testing for BRCA1 and BRCA2 genes.
- PMID: 24841458
- PubMed abstract
- Source abstract
-
- [Current Clinical Issues and Recent Trends in Hereditary Breast and Ovarian Cancer in Japan-Genetic Testing for HBOC and Risk-Reducing Surgery].
- Arai M, Iwase T, Takazawa Y, Takeshima N.
- Gan To Kagaku Ryoho. 2014 Nov;41(11):1333-9.
- PMID: 25434434
- PubMed abstract
- Source abstract
-
- Current strategies for the prevention of breast cancer.
- Advani P, Moreno-Aspitia A.
- Breast Cancer (Dove Med Press). 2014 May 2;6:59-71. doi: 10.2147/BCTT.S39114. eCollection 2014.
- PMID: 24833917
- PubMed abstract
- Source abstract
- Review
- Free PMC article
- Free Full Text
-
- Management of women at high risk of breast cancer.
- Armstrong AC, Evans GD.
- BMJ. 2014 Apr 28;348:g2756. doi: 10.1136/bmj.g2756.
- PMID: 24778341
- PubMed abstract
- Source abstract
-
- Did we need a new Angelina Jolie to discuss about prophylactic surgery for colon cancer because of Mister Lynch's silence?
- Pocard M.
- J Visc Surg. 2014 Feb;151(1):1-2. doi: 10.1016/j.jviscsurg.2013.11.001. Epub 2013 Dec 25.
- PMID: 24373720
- PubMed abstract
- Source abstract
-
- Honing the Health Message on BRCA Mutations.
- Schmidt C.
- J Natl Cancer Inst. 2013 Dec 18;105(24):1843-4. doi: 10.1093/jnci/djt364. Epub 2013 Dec 6.
- PMID: 24316597
- PubMed abstract
- Source abstract
- News
- Free Full Text
-
- Tubal ligation, hysterectomy and epithelial ovarian cancer in the New England Case-Control Study.
- Rice MS, Murphy MA, Vitonis AF, Cramer DW, Titus LJ, Tworoger SS, Terry KL.
- Int J Cancer. 2013 Nov 15;133(10):2415-21. doi: 10.1002/ijc.28249. Epub 2013 Jul 9.
- PMID: 23650079
- PubMed abstract
- Source abstract
-
- Local approaches to hereditary breast cancer.
- Cooper BT, Murphy JO, Sacchini V, Formenti SC.
- Ann Oncol. 2013 Nov;24 Suppl 8:viii54-viii60. doi: 10.1093/annonc/mdt327.
- PMID: 24131971
- PubMed abstract
- Source abstract
- Review
- Free Full Text
-
- Challenging and complex decisions in the management of the BRCA mutation carrier.
- Stan DL, Shuster LT, Wick MJ, Swanson CL, Pruthi S, Bakkum-Gamez JN.
- J Womens Health (Larchmt). 2013 Oct;22(10):825-34. doi: 10.1089/jwh.2013.4407. Epub 2013 Aug 29.
- PMID: 23987739
- PubMed abstract
- Source abstract
- Review
- Free PMC article
-
- [Characteristics of selected clinical features in BRCA1 mutation carriers affected with breast cancer undergoing preventive female genital tract surgeries].
- Menkiszak J, Chudecka-Głaz A, Gronwald J, Bedner R, Cymbaluk-Płoska A, Wezowska M, Zielińska D, Rzepka-Górska I.
- Ginekol Pol. 2013 Sep;84(9):758-64.
- PMID: 24191513
- PubMed abstract
- Source abstract
- [Article in Polish]
- Free Full Text
-
- First Man Has Prostatectomy Because of BRCA Gene Mutation.
- Zosia Chustecka.
- Medscape Medical News. Oncology. 2013 May 20.
- News
- Free Full Text
-
- [Choices for women at risk of hereditary breast cancer].
- Saadatmand S, Obdeijn IM, Koppert LB, Tilanus-Linthorst M.
- Ned Tijdschr Geneeskd. 2013;157(43):A6625.
- PMID: 24152366
- PubMed abstract
- Source abstract
-
- [Methods of surgical prevention of breast cancer and of ovarian cancer in BRCA mutation carriers].
- Bit-Sava EM, Belogurova MB, Imianitov EN, Balandov SG, Korniushin OV, Borisov MK.
- Vopr Onkol. 2013;59(2):5-11.
- PMID: 23814843
- PubMed abstract
-
- [Prophylactic surgery in common hereditary cancer syndromes].
- Noguès C, Mouret-Fourme E.
- Bull Acad Natl Med. 2012 Oct;196(7):1237-45.
- PMID: 23815011
- PubMed abstract
- Archive
- Review, [Article in French]
- Free Full Text (PDF of issue)
-
- Risk-reducing Surgery in Women at Risk for Familial Breast or Ovarian Cancer.
- Rhiem K, Pfeifer K, Schmutzler RK, Kiechle M.
- Geburtshilfe Frauenheilkd. 2012 Sep;72(9):833-839.
- PMID: 26640291
- PubMed abstract
- Source abstract
- Review
- Free PMC article
- Free Full Text
-
- A simulation model to predict the impact of prophylactic surgery and screening on the life expectancy of BRCA1 and BRCA2 mutation carriers.
- Sigal BM, Munoz DF, Kurian AW, Plevritis SK.
- Cancer Epidemiol Biomarkers Prev. 2012 Jul;21(7):1066-77. doi: 10.1158/1055-9965.EPI-12-0149. Epub 2012 May 3.
- PMID: 22556274
- PubMed abstract
- Source abstract
-
- Managing the breast in patients who test positive for hereditary breast cancer.
- Euhus D.
- Ann Surg Oncol. 2012 Jun;19(6):1738-44. doi: 10.1245/s10434-012-2258-x. Epub 2012 Mar 7.
- PMID: 22395981
- PubMed abstract
- Source abstract
-
- Practice Patterns of Hereditary Ovarian Cancer Management in Korea.
- Choi MC, Lim MC, Lee M, Kim MK, Suh DH, Song YJ, Kim TJ, Chang SJ, Kim JW.
- Int J Gynecol Cancer. 2017 Jun;27(5):895-899. doi: 10.1097/IGC.0000000000000964.
- PMID: 28498247
- PubMed abstract
- Source abstract
-
- Prevention of breast cancer in the context of a national breast screening programme.
- Howell A, Astley S, Warwick J, Stavrinos P, Sahin S, Ingham S, McBurney H, Eckersley B, Harvie M, Wilson M, Beetles U, Warren R, Hufton A, Sergeant J, Newman W, Buchan I, Cuzick J, Evans DG.
- J Intern Med. 2012 Apr;271(4):321-30. doi: 10.1111/j.1365-2796.2012.02525.x.
- PMID: 22292490
- PubMed abstract
- Source abstract
- Review
- Free Full Text